The Vietnam-focused venture firm’s maiden fund has attracted commitments from limited partners Naver, Sea and Woowa Brothers on the way to a $50m target.

The $14.6m round was co-led by distribution partner Fosun Pharma and also featured existing investor Baidu Ventures,

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Grifols has acquired its existing portfolio company Alkahest, five years after buying a 45% stake in the Stanford University spinout.

Grifols agreed the deal five years after supplying $50m in equity and development financing for the neurodegenerative disease therapy developer.

The single-cell diagnostics technology provider closed a series A round led by Lilly Asia Ventures that also featured Tencent.

Japan Post Investment Corporation and Astellas Venture Management backed a series C round that will fund preclinical and clincical trials of the company's radiotherapy system.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Boston Scientific owns more than 30% of the emphysema treatment device developer, which is targeting $86.3m in its offering.

Backed by Research Institute of Tsinghua University in Shenzhen, CoWin Biosciences supplies biological reagents for diagnostics and research applications.